Status: Recruiting
Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation
This study is an investigator-initiated prospective, single-center, open-label clinical trial designed to evaluate the clinical efficacy and safety of Lusutrombopag in promoting platelet remodeling after allogeneic hematopoietic stem cell transplantation in patients with hematologic disorders.
Participants needed: 45
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: The General Hospital of Western Theater CommandUpdated: Mar 25, 2026Locations: 1
Eligibility criteria
The patient signed an informed consent form and voluntarily participated in the... [+5]